Five-year cancer survival rates for each stage of cancer is lower in nonmetropolitan areas for Black and White individuals in the US.

Three presentations at ESMO 2025 will demonstrate Lunit SCOPE IO’s value in predicting immunotherapy response in colorectal, ...

Discover how rectal spacers revolutionize prostate cancer treatment by reducing side effects and enhancing radiation dose ...

Researchers uncover that rectal spacers significantly enhance cancer cure rates, reducing treatment failure by 50% in ...

Cancer rates and costs are rising nationwide. Learn how employers can support early detection, prevention, and whole-person ...

AI-powered histopathology demonstrates predictive value for immunotherapy outcomes in pMMR mCRC, advanced ccRCC, and NSCLC with data featured in both oral and poster presentations ...

To improve the quality of life of people with cancer, oncologists have regularly recommended exercise. Staying fit can make ...

Both medication-based and surgical weight loss interventions were linked to lower rates of obesity-related cancers in people with obesity and T2D.

Depression may affect a person’s likelihood of achieving optimal recovery after cancer surgery, according to retrospective ...

Massive price disparities, as well as "zombie" prices for procedures that hospitals don't actually perform, paint a bleak ...

Shares of mid-cap oncology specialist Exelixis are worth about $39 each right now. The biotech generates steady revenue and ...

Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its self-developed CDH17-targeting ADC (R&D code: 7MW4911) received IND clearance from the ...